Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial
Results and Conference Call
ALISO VIEJO, Calif., May 1, 2013
ALISO VIEJO, Calif., May 1, 2013 /PRNewswire/ --Avanir Pharmaceuticals, Inc.
(NASDAQ: AVNR) will report financial results for the quarter ended March 31,
2013 after market close on Wednesday May 8, 2013. The company will conduct a
conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern
Time) on the same day.
Conference Call Information:
Domestic callers: 1 (877) 703 6106
International callers: +1 (857) 244-7305
Webcast information: Visit http://ir.avanir.com.
A webcast replay will be available on the Avanir Web site for 30 days. A
telephone replay will be available for 48 hours following the conclusion of
the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617)
801-6888 for international callers, and entering reservation code 76137052.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on
bringing innovative medicines to patients with central nervous system
disorders of high unmet medical need. As part of our commitment, we have
extensively invested in our pipeline and are dedicated to advancing medicines
that can substantially improve the lives of patients and their loved ones. For
more information about Avanir, please visit www.avanir.com.
AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.
SOURCE Avanir Pharmaceuticals, Inc.
Contact: Ian Clements, PhD, +1 (949) 389-6700, email@example.com
Press spacebar to pause and continue. Press esc to stop.